<Record>
<Term>Adenovirus 5-Tumor Necrosis Factor Alpha</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Adenovirus Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Recombinant Viral Vaccine/Adenovirus Vaccine/Adenovirus 5-Tumor Necrosis Factor Alpha</ClassificationPath>
<BroaderTerm>Adenovirus Vaccine</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Recombinant Viral Vaccine</BroaderTerm>
<BroaderTerm>Adenovirus 5-Tumor Necrosis Factor Alpha</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Ad 5-TNF Alpha</Synonym>
<Synonym>Adenovirus 5-Tumor Necrosis Factor Alpha</Synonym>
<Description>A recombinant agent consisting of a genetically-modified adenovirus 5 vector encoding the protein cytokine tumor necrosis factor (TNF) alpha.  TNF exhibits potent anti-tumor cytolytic properties; the adenovirus 5 vector efficiently infects tumor cells, delivering tumor-specific TNF. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
